Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hereditary hemocromatosis].

Massimo Franchini1, Dino Veneri

  • 1Servizio di Immunoematologia e Trasfusione, Azienda Ospedaliera, Verona. massimo.franchini@mail.azosp.vr.it

Recenti Progressi in Medicina
|November 25, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An unusual case of sodium citrate-dependent artifactual platelet count.

Interventional medicine & applied science·2022
Same author

Pathogenesis of immune thrombocytopenia in common variable immunodeficiency.

Autoimmunity reviews·2020
Same author

Is triple-positive serology for Epstein-Barr virus (VCA-IgG, VCA-IgM, EBNA-IgG) a specific feature of angioimmunoblastic T-cell lymphoma?

Tumori·2019
Same author

Eltrombopag for the treatment of inherited thrombocytopenias: a phase II clinical trial.

Haematologica·2019
Same author

Calcium-Dependent Src Phosphorylation and Reactive Oxygen Species Generation Are Implicated in the Activation of Human Platelet Induced by Thromboxane A2 Analogs.

Frontiers in pharmacology·2018
Same author

Primary sphenoid lymphoma: Focus on imaging.

Tumori·2018
Same journal

Recenti progressi in medicina·2026
Same journal

Recenti progressi in medicina·2026
Same journal

Recenti progressi in medicina·2026
Same journal

Recenti progressi in medicina·2026
Same journal

Recenti progressi in medicina·2026
Same journal

Recenti progressi in medicina·2026
See all related articles

Hereditary hemochromatosis, a disorder causing iron overload, can be detected using transferrin saturation and serum ferritin tests. Early phlebotomy treatment prevents organ damage and ensures normal life expectancy.

Area of Science:

  • Genetics and Molecular Medicine
  • Metabolic Disorders
  • Hematology

Background:

  • Hereditary hemochromatosis involves progressive iron overload, potentially causing irreversible organ damage.
  • Molecular medicine advancements have improved understanding of its pathophysiology and diagnosis.
  • Timely intervention is crucial for managing hereditary hemochromatosis.

Purpose of the Study:

  • To summarize the current understanding of hereditary hemochromatosis.
  • To highlight key diagnostic markers and treatment strategies.
  • To emphasize the importance of early detection and intervention.

Main Methods:

  • Review of recent developments in molecular medicine related to hereditary hemochromatosis.
  • Evaluation of established diagnostic tests: transferrin saturation and serum ferritin.

Related Experiment Videos

  • Assessment of therapeutic phlebotomy as a primary treatment modality.

    • Main Results:

    • Transferrin saturation and serum ferritin remain the most reliable diagnostic indicators.
    • Therapeutic phlebotomy is the cornerstone of hereditary hemochromatosis management.
    • Early initiation of phlebotomy before irreversible organ damage leads to normal life expectancy.

    Conclusions:

    • Hereditary hemochromatosis requires timely diagnosis and treatment to prevent organ damage.
    • Molecular medicine has enhanced the understanding and diagnosis of this iron metabolism disorder.
    • Effective management through phlebotomy can normalize life expectancy for affected individuals.